Life with Cancer: Anxiety in Grief

grieving woman resting her head on her knees

By Sarah Brooks, LPC, Oncology Clinical Therapist, Inova Life with Cancer “No one ever told me grief felt so like fear.” – C.S. Lewis When we are grieving, anxiety may emerge as part of our experience. Anxious thoughts and concurrent bodily responses can be adaptive in certain situations, but when they begin to pervade our…

Read More

Cancer News: A Look at The Future of Targeted Therapy

older couple looking at a laptop

In the past, chemotherapy treatment was given to patients based on where in the body the cancer began, not taking in the factors of the molecular diversity of the individual patient’s cancer. Over the years, the development and advancement of the treatment for cancer has improved by applying molecular testing to determine individual patient tumors…

Read More

Should You Get a Mammogram During COVID-19?

Lucy De La Cruz, MD, is fellowship-trained in breast surgery and board-certified in general surgery. She specializes in the surgical management of benign and malignant breast disease. In the first months of the COVID-19 pandemic, many people sheltered in place and avoided unnecessary activities outside the home, including elective medical appointments. But it’s a mistake…

Read More

Free Webinar Oct. 17: Can Diet Help Reduce Cancer Risk?

fruits and vegetables

Online Zoom session: Saturday, Oct. 17 – 9 to 11 a.m. Register at Did you know you can help protect yourself against cancer using food? Inova oncology registered dietitian Lauren Fay says that, aside from not smoking, maintaining a healthy weight throughout life is the best way to protect against cancer. Lauren is leading…

Read More

Inova’s Dr. Aragon-Ching Part of International Team Showing Benefit of Immunotherapy in Bladder Cancer Treatment

image of a hand outstretched towards a sunny lake

Jeanny B. Aragon-Ching, MD of the Inova Schar Cancer Institute has co-authored a groundbreaking bladder cancer research paper just published in the New England Journal of Medicine. The large phase III clinical study showed that the addition of immunotherapy with Avelumab (Bavencio) increased the duration of overall survival by almost 50% in patients when given…

Read More